Clinical Trials Logo
  1. Home
  2. Heart Arrest
  3. NCT02486211

Amantadine to Speed Awakening After Cardiac Arrest — AWAKE  

Heart Arrest Clinical Trial

Official title:
Amantadine to Speed Awakening After Cardiac Arrest

Clinical Trial Summary

This study evaluates if amantadine will increase the rate of awakening in patients resuscitated from cardiac arrest but comatose (not following commands) after their resuscitation. Half of the participants will receive amantadine and the other will receive placebo.

Clinical Trial Description

Amantadine has been used to help patients awaken following traumatic brain injury, but it has not been studied in patients with anoxic brain injury.

Amantadine is a dopamine agonist and may help with stimulating the brain to awaken. The investigators will randomize subjects who remain comatose 72 hours following resuscitation from cardiac arrest to either amantadine or placebo. They will be treated with either amantadine or placebo for 7 days. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02486211
Study type Interventional
Source University of Pittsburgh
Contact
Status Completed
Phase Phase 2
Start date September 2015
Completion date June 30, 2018
View Details
See also
  Status Clinical Trial Phase
Completed NCT04078815 - End-of-life Practices in 2019 vs. 2014
Completed NCT02816385 - Study of Myocardial Contractility After Cardiac Surgery Under an Anterograde or Retrograde Cardioplegia N/A
Recruiting NCT02326506 - Evaluation of Drainable Volume Measurements During VA-ELS N/A
Completed NCT00139542 - AED Use in Out-of-Hospital Cardiac Arrest: A New Algorithm Named "One Shock Per Minute" Phase 3
Completed NCT00004560 - Public Access Defibrillation (PAD) Community Trial Phase 3
Completed NCT00000502 - Evaluation of SC-V Versus Conventional CPR Phase 3
Completed NCT03640949 - Vasopressin and Methylprednisolone for In-Hospital Cardiac Arrest Phase 2/Phase 3
Completed NCT03310450 - Tour de Borobudur Troponin Study on Predictors and Synergistic Role of MDA and Hs-CRP Levels
Not yet recruiting NCT06048796 - Early Cessation of Sedation and TTM in Patients With a Favourable EEG After Cardiac Arrest N/A
Completed NCT02733146 - Histones and Free-plasma DNA After Cardiac Arrest N/A
Withdrawn NCT01082991 - Patient Acuity Rating: a Tool to Prevent In-Hospital Cardiac Arrest Phase 0
Terminated NCT00189423 - ResQ Trial: Impact of an ITD and Active Compression Decompression CPR on Survival From Out-of-Hospital Cardiac Arrest N/A
Completed NCT00172354 - Hydrocortisone in Patients of Out-of-hospital Cardiac Arrest N/A
Completed NCT02858583 - SI + CC Versus 3:1 C:V Ratio During Neonatal CPR N/A
Completed NCT03664557 - Feasibility of REBOA in Refractory Cardiac Arrest N/A
Completed NCT01968148 - Mechanisms of Ultra-acute Hyperglycemia After Successful Resuscitation From Out-of-hospital Cardiac Arrest N/A
Completed NCT00392639 - Clinical and Economical Interest of Endovascular Cooling in the Management of Cardiac Arrest (ICEREA Study) Phase 4
Recruiting NCT06081283 - Antiseizure Medication in Seizure Networks at Early Acute Brain Injury Phase 4
Recruiting NCT05321459 - Predictive Outcome in Comatose Patients
Completed NCT02780050 - Influence of Core Muscles Activation Using Physical Fitness on the Performance of Chest Compression N/A